The Battle for Market Share: Why Biosimilars Struggle to Capture the Market
Humira biosimilars began entering the market in January 2023, with 10 now FDA-approved.
top of page
Michael is an accomplished global pharmaceutical executive with nearly 30 years of experience. Here he shares his insights on leadership and his extensive knowledge of the pharmaceutical and healthcare industries.
Sign Up For Michael's Newsletter
Latest Articles
bottom of page